Life Sciences Tools and Services
Company Overview of Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc., a consulting company, provides national and international regulatory and product development advice on the development and commercial production of biological, drug, and device products. It offers clinical development services, such as study set-up and study documentation services, as well as FDA IND submission and maintenance services, such as study management and monitoring, advisory board, biostatistical analysis and data management, and medical writing services. The company also provides electronic submissions services; audit and inspection services, including inspection of manufacturing facilities, audit of system/process validation studies, evaluation ...
400 North Washington Street
Alexandria, VA 22314
Founded in 1993
Key Executives for Biologics Consulting Group, Inc.
Chief Executive Officer and President
Vice President of Finance
Consultant and Presiden ot BCG-Japan
Compensation as of Fiscal Year 2013.
Biologics Consulting Group, Inc. Key Developments
Biologics Consulting Group, Inc. Presents at World Vaccine Congress Washington 2013, Apr-16-2013 12:35 PM
Mar 26 13
Biologics Consulting Group, Inc. Presents at World Vaccine Congress Washington 2013, Apr-16-2013 12:35 PM. Venue: Gaylord National Hotel and Convention Center, Washington, District Of Columbia, United States. Speakers: Trent A. Carrier, Executive Director of Business Strategy.
Biologics Consulting Group, Inc. Presents at 2012 BIO International Convention, Jun-18-2012
May 31 12
Biologics Consulting Group, Inc. Presents at 2012 BIO International Convention, Jun-18-2012 . Venue: Beston Convention & Exhition Center, Boston, Massachusetts, United States. Speakers: Norman W. Baylor, Chief Executive Officer and President.
Immunovative Therapies, Ltd. Retains Andra E. Miller and Holly M. Scott of Biologics Consulting Group
Mar 15 12
Novo Energies Corporation announced that Immunovative Therapies Ltd. has retained the services of Andra E. Miller, Ph.D. and Holly M. Scott of Biologics Consulting Group, Inc. to provide Immunovative with in-depth assistance and compliance with U.S. Food and Drug Administration (FDA) regulations and requirements with respect to Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP). The appointments of Dr. Miller and Ms. Scott are part of Immunovative's commitment to build a world-class clinical research and GMP biologics manufacturing organization. Andra Miller, Ph.D. is the Director, Cell and Gene Therapies for Biological Consulting Group. The focus of Dr. Miller's consulting with Immunovative will be to advise on regulatory strategies for product development, including interpretation of FDA guidelines, assisting in the review and preparation of FDA submissions, and providing advice on cGMP and quality system development and compliance. Holly Scott joined Biologics Consulting Group as a Senior Consultant in 2009. Ms. Scott will use her experience to provide a continuous program of compliance analysis of both the Immunovative's manufacturing operations under GMP and the clinical operations under GCP.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|